These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7033993)

  • 1. Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
    Høvding G
    Pharmatherapeutica; 1981; 3(1):61-6. PubMed ID: 7033993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S; Hagemeier HH
    Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diprosalic in the therapy of psoriasis and atopic dermatitis].
    Krivosheev BN
    Voen Med Zh; 1999 Mar; 320(3):39-40. PubMed ID: 10319709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the efficacy of and tolerance of betamethasone 17,21 dipropionate and salicylic acid in dermatoses of the scalp].
    Bosco G
    G Ital Dermatol Venereol; 1985; 120(2):XXV-XXVII. PubMed ID: 4007947
    [No Abstract]   [Full Text] [Related]  

  • 11. Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
    Malfitan VA
    Clin Ther; 1983; 5(3):290-8. PubMed ID: 6850723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
    Cassano N; Vena GA
    Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
    [No Abstract]   [Full Text] [Related]  

  • 13. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
    Elie R; Durocher LP; Kavalec EC
    J Int Med Res; 1983; 11(2):108-12. PubMed ID: 6852357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 16. Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
    Downs AM
    Acta Derm Venereol; 2006; 86(1):57-8. PubMed ID: 16585991
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
    Hillström L; Pettersson L; Svensson L
    J Int Med Res; 1982; 10(6):419-22. PubMed ID: 7152080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
    Eichenfield LF; Ganslandt C; Kurvits M; Schlessinger J
    Pediatr Dermatol; 2015; 32(1):28-35. PubMed ID: 25412565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.